Download pdf - Hemolytic Anemia.ppt

Transcript
  • 7/27/2019 Hemolytic Anemia.ppt

    1/43

    HEMOLYTIC ANEMIAS

  • 7/27/2019 Hemolytic Anemia.ppt

    2/43

    HEMOLYTIC ANEMIA

    Anemia of increased destruction

    Normochromic, normochromic anemia

    Shortened RBC survival Reticulocytosis - Response to increased

    RBC destruction

    Increased indirect bilirubin

    Increased LDH

  • 7/27/2019 Hemolytic Anemia.ppt

    3/43

    HEMOLYTIC ANEMIATesting

    Absent haptoglobin Hemoglobinuria

    Hemoglobinemia

  • 7/27/2019 Hemolytic Anemia.ppt

    4/43

  • 7/27/2019 Hemolytic Anemia.ppt

    5/43

    HEMOLYTIC ANEMIACauses

    INTRACORPUSCULAR HEMOLYSIS

    Membrane Abnormalities

    Metabolic Abnormalities Hemoglobinopathies

    EXTRACORPUSCULAR HEMOLYSIS

    Nonimmune Immune

  • 7/27/2019 Hemolytic Anemia.ppt

    6/43

    HEMOLYTIC ANEMIAMembrane Defects

    Microskeletal defects

    Hereditary spherocytosis

    Membrane permeability defects Hereditary stomatocytosis

    Increased sensitivity to complement

    Paroxysmal nocturnal hemoglobinuria

  • 7/27/2019 Hemolytic Anemia.ppt

    7/43

    RED CELL CYTOSKELETON

  • 7/27/2019 Hemolytic Anemia.ppt

    8/43

    HEREDITARY SPHEROCYTOSIS

    Defective or absent spectrin molecule

    Leads to loss of RBC membrane,

    leading to spherocytosis Decreased deformability of cell

    Increased osmotic fragility

    Extravascular hemolysis in spleen

  • 7/27/2019 Hemolytic Anemia.ppt

    9/43

  • 7/27/2019 Hemolytic Anemia.ppt

    10/43

    SPLENIC ARCHITECTURE

  • 7/27/2019 Hemolytic Anemia.ppt

    11/43

    HEREDITARY SPHEROCYTOSISOsmotic Fragility

    0

    20

    40

    60

    80

    100

    0.3 0.4 0.5 0.6

    NaCl (% of normal saline)

    %Hemolysis

    Normal HS

  • 7/27/2019 Hemolytic Anemia.ppt

    12/43

    Paroxysmal NocturnalHemoglobinuria

    Clonal cell disorder

    Ongoing Intra- & Extravascular hemolysis;classically at night

    TestingAcid hemolysis (Ham test)

    Sucrose hemolysis

    CD-59 negative (Product of PIG-A gene)

    Acquired deficit of GPI-Associated proteins(including Decay Activating Factor)

  • 7/27/2019 Hemolytic Anemia.ppt

    13/43

  • 7/27/2019 Hemolytic Anemia.ppt

    14/43

    GPI BRIDGE

  • 7/27/2019 Hemolytic Anemia.ppt

    15/43

    Paroxysmal NocturnalHemoglobinuria

    GPI Proteins

    GPI links a series of proteins to outer leaf ofcell membrane via phosphatidyl inositolbridge, with membrane anchor viadiacylglycerol bridge

    PIG-A gene, on X-chromosome, codes forsynthesis of this bridge; multiple defectsknown to cause lack of this bridge

    Absence of decay accelerating factor leads to

    failure to inactivate complement & thereby toincreased cell lysis

  • 7/27/2019 Hemolytic Anemia.ppt

    16/43

    HEMOLYTIC ANEMIAMembrane abnormalities - Enzymopathies

    Deficiencies in Hexose MonophosphateShunt

    Glucose 6-Phosphate DehydrogenaseDeficiency

    Deficiencies in the EM Pathway

    Pyruvate Kinase Deficiency

  • 7/27/2019 Hemolytic Anemia.ppt

    17/43

    G6PD DEFICIENCYFunction of G6PD

    G6PD

    GSSG 2 GSH

    NADPH NADP

    2 H2O H2O2

    6-PG G6P

    Hgb

    Sulf-Hgb

    Heinz bodies

    Hemolysis

    Infections

    Drugs

  • 7/27/2019 Hemolytic Anemia.ppt

    18/43

    Glucose 6-Phosphate DehydrogenaseFunctions

    Regenerates NADPH, allowing regeneration ofglutathione

    Protects against oxidative stress

    Lack of G6PD leads to hemolysis duringoxidative stress Infection

    Medications

    Fava beans

    Oxidative stress leads to Heinz bodyformation,extravascular hemolysis

  • 7/27/2019 Hemolytic Anemia.ppt

    19/43

    Glucose 6-Phosphate DehydrogenaseDifferent Isozymes

    0

    0.2

    0.4

    0.6

    0.8

    1

    0 20 40 60 80 100 120

    RBC Age (Days)

    G6PDAc

    tivity(%)

    Normal (GdB) Black Variant (GdA-)

    Mediterranean (Gd Med)

    Level needed for protection vsordinary oxidative stress

  • 7/27/2019 Hemolytic Anemia.ppt

    20/43

  • 7/27/2019 Hemolytic Anemia.ppt

    21/43

    HEMOLYTIC ANEMIACauses

    INTRACORPUSCULAR HEMOLYSIS

    Membrane Abnormalities

    Metabolic Abnormalities Hemoglobinopathies

    EXTRACORPUSCULAR HEMOLYSIS

    Nonimmune Immune

  • 7/27/2019 Hemolytic Anemia.ppt

    22/43

    EXTRACORPUSCULAR HEMOLYSISNonimmune

    Mechanical

    Infectious Chemical

    Thermal

    Osmotic

  • 7/27/2019 Hemolytic Anemia.ppt

    23/43

    Microangiopathic Hemolytic AnemiaCauses

    Vascular abnormalities Thrombotic thrombocytopenic purpura

    Renal lesions

    Malignant hypertension Glomerulonephritis

    Preeclampsia

    Transplant rejection

    Vasculitis

    Polyarteritis nodosa Rocky mountain spotted fever

    Wegeners granulomatosis

  • 7/27/2019 Hemolytic Anemia.ppt

    24/43

    Microangiopathic Hemolytic AnemiaCauses - #2

    Vascular abnormalities

    AV Fistula Cavernous hemangioma

    Intravascular coagulation predominant

    Abruptio placentae

    Disseminated intravascular coagulation

  • 7/27/2019 Hemolytic Anemia.ppt

    25/43

  • 7/27/2019 Hemolytic Anemia.ppt

    26/43

    IMMUNE HEMOLYTIC ANEMIAGeneral Principles

    All require antigen-antibody reactions

    Types of reactions dependent on: Class of Antibody

    Number & Spacing of antigenic sites on cellAvailability of complement

    Environmental Temperature

    Functional status of reticuloendothelial system

    Manifestations Intravascular hemolysis

    Extravascular hemolysis

  • 7/27/2019 Hemolytic Anemia.ppt

    27/43

    IMMUNE HEMOLYTIC ANEMIAGeneral Principles - 2

    Antibodies combine with RBC, & either1. Activate complement cascade, &/or2. Opsonize RBC for immune system

    If 1, if all of complement cascade isfixed to red cell, intravascular cell lysisoccurs

    If 2, &/or if complement is onlypartially fixed, macrophages recognizeFc receptor of Ig &/or C3b ofcomplement & phagocytize RBC,causing extravascular RBC destruction

  • 7/27/2019 Hemolytic Anemia.ppt

    28/43

    IMMUNE HEMOLYTIC ANEMIACoombs Test - Direct

    Looks for immunoglobulin &/or complementof surface of red blood cell (normally neitherfound on RBC surface)

    Coombs reagent - combination of anti-humanimmunoglobulin & anti-human complement

    Mixed with patients red cells; if

    immunoglobulin or complement are onsurface, Coombs reagent will link cellstogether and cause agglutination of RBCs

  • 7/27/2019 Hemolytic Anemia.ppt

    29/43

    IMMUNE HEMOLYTIC ANEMIACoombs Test - Indirect

    Looks for anti-red blood cell antibodies in

    the patients serum, using a panel of redcells with known surface antigens

    Combine patients serum with cells from apanel of RBCs with known antigens

    Add Coombs reagent to this mixture

    If anti-RBC antigens are in serum,agglutination occurs

  • 7/27/2019 Hemolytic Anemia.ppt

    30/43

    HEMOLYTIC ANEMIA - IMMUNE

    Drug-Related Hemolysis

    Alloimmune Hemolysis

    Hemolytic Transfusion Reaction Hemolytic Disease of the Newborn

    Autoimmune Hemolysis

    Warm autoimmune hemolysis Cold autoimmune hemolysis

  • 7/27/2019 Hemolytic Anemia.ppt

    31/43

    IMMUNE HEMOLYSISDrug-Related

    Immune Complex Mechanism

    Quinidine, Quinine, Isoniazid

    Haptenic Immune Mechanism Penicillins, Cephalosporins

    True Autoimmune Mechanism

    Methyldopa, L-DOPA, Procaineamide,Ibuprofen

  • 7/27/2019 Hemolytic Anemia.ppt

    32/43

    DRUG-INDUCED HEMOLYSISImmune Complex Mechanism

    Drug & antibody bind in the plasma

    Immune complexes either

    Activate complement in the plasma, or Sit on red blood cell

    Antigen-antibody complex recognized by REsystem

    Red cells lysed as innocent bystander ofdestruction of immune complex

    REQUIRES DRUG IN SYSTEM

  • 7/27/2019 Hemolytic Anemia.ppt

    33/43

    DRUG-INDUCED HEMOLYSISHaptenic Mechanism

    Drug binds to & reacts with red cellsurface proteins

    Antibodies recognize altered protein, drug, as foreign

    Antibodies bind to altered protein &initiate process leading to hemolysis

  • 7/27/2019 Hemolytic Anemia.ppt

    34/43

    DRUG-INDUCED HEMOLYSISTrue Autoantibody Formation

    Certain drugs appear to causeantibodies that react with antigensnormally found on RBC surface, and doso even in the absence of the drug

  • 7/27/2019 Hemolytic Anemia.ppt

    35/43

    ALLOIMUNE HEMOLYSIS

    Hemolytic Transfusion Reaction

    Caused by recognition of foreign antigens ontransfused blood cells

    Several types Immediate Intravascular Hemolysis (Minutes) - Due topreformed antibodies; life-threatening

    Slow extravascular hemolysis (Days) - Usually due torepeat exposure to a foreign antigen to which there

    was a previous exposure; usually only mild symptoms Delayed sensitization - (Weeks) - Usually due to 1st

    exposure to foreign antigen; asymptomatic

  • 7/27/2019 Hemolytic Anemia.ppt

    36/43

    INCOMPATIBLE RBC TRANSFUSIONRate of Hemolysis

    0

    20

    40

    60

    80

    100

    0 1 2 3 4 5 6 7

    Weeks Post-Transfusion

    Surviving

    Cells(%)

    Normal Immediate Intravascular Hemolysis

    Slow Extravascular Hemolysis Delayed Extravascular Hemolysis

  • 7/27/2019 Hemolytic Anemia.ppt

    37/43

    ALLOIMMUNE HEMOLYSISTesting Pre-transfusion

    ABO & Rh Type of both donor &recipient

    Antibody Screen of Donor & Recipient,including indirect Coombs

    Major cross-match by same procedure(recipient serum & donor red cells)

  • 7/27/2019 Hemolytic Anemia.ppt

    38/43

    ALLOIMMUNE HEMOLYSISHemolytic Disease of the Newborn

    Due to incompatibility between mothernegative for an antigen & fetus/fatherpositive for that antigen. Rh incompatibility,

    ABO incompatibility most common causes Usually occurs with 2nd or later pregnancies

    Requires maternal IgG antibodies vs.RBC

    antigens in fetus

  • 7/27/2019 Hemolytic Anemia.ppt

    39/43

    ALLOIMMUNE HEMOLYSISHemolytic Disease of the Newborn - #2

    Can cause severe anemia in fetus, witherythroblastosis and heart failure

    Hyperbilirubinemia can lead to severe brain

    damage (kernicterus) if not promptly treated

    HDN due to Rh incompatibility can be almosttotally prevented by administration of anti-Rh

    D to Rh negative mothers after eachpregnancy

  • 7/27/2019 Hemolytic Anemia.ppt

    40/43

    AUTOIMMUNE HEMOLYSIS

    Due to formation of autoantibodies thatattack patients own RBCs

    Type characterized by ability ofautoantibodies to fix complement & siteof RBC destruction

    Often associated with eitherlymphoproliferative disease or collagenvascular disease

  • 7/27/2019 Hemolytic Anemia.ppt

    41/43

    AUTOIMMUNE HEMOLYSISWarm Type

    Usually IgG antibodies

    Fix complement only to level of C3,if at all

    Immunoglobulin binding occurs at all temps

    Fc receptors/C3b recognized bymacrophages;

    Hemolysis primarily extravascular

    70% associated with other illnesses

    Responsive to steroids/splenectomy

  • 7/27/2019 Hemolytic Anemia.ppt

    42/43

    AUTOIMMUNE HEMOLYSISCold Type

    Most commonly IgM mediated

    Antibodies bind best at 30 or lower

    Fix entire complement cascade

    Leads to formation of membrane attackcomplex, which leads to RBC lysis invasculature

    Typically only complement found on cells

    90% associated with other illnesses

    Poorly responsive to steroids, splenectomy;responsive to plasmapheresis

  • 7/27/2019 Hemolytic Anemia.ppt

    43/43

    HEMOLYTIC ANEMIASummary

    Myriad causes of increased RBCdestruction

    Marrow function usually normal

    Often requires extra folic acid tomaintain hematopoiesis

    Anything that turns off the bone

    marrow can result in acute, life-threatening anemia


Recommended